Skip to main content

Tweets

Day 2 Report - ACR Plenaries: Changing the Practice of Rheumatology The top ACR2023 Plenary abstracts Dr. Dao ( @kdao2011) found impactful for her practice were... https://t.co/aXut7l7b79 https://t.co/ATO5r5OzGK
Dr. John Cush @RheumNow ( View Tweet )
2 years 7 months ago
ACR23 – Day 3 Report F2F learning amidst miles of research and many young talented aside wizened establish presenters is such a welcome return to ACR, the way it should be. https://t.co/TwmwfEQZdp https://t.co/Yo27c7ig8N
Dr. John Cush @RheumNow ( View Tweet )
2 years 7 months ago
Watch: Lupus Nephritis Therapy Paradigm Shift Dr. Yuz Yusof reporting on abstract 0782 at the 2023 ACR Convergence meeting in San Diego, CA. https://t.co/poIVX74EnO https://t.co/tWlRlwTfH0
Dr. John Cush @RheumNow ( View Tweet )
2 years 7 months ago
IV Secukinumab for AxSpa The FDA recently announced approval for intravenous secukinumab (Cosentyx) for adults with psoriatic arthritis, ankylosing spondylitis, and non-radiographic spondylitis. https://t.co/eDAWevPLkE https://t.co/AlWYGAQP5T
Dr. John Cush @RheumNow ( View Tweet )
2 years 7 months ago
Secukinumab vs. Adalimumab Biosimilar on Radiographic Progression in AxSpA Dr. Robert Chao (Tysons, VA) discusses Abstract 0522 presented at the 2023 ACR Convergence meeting in San Diego, CA. https://t.co/UmcbplfGhB https://t.co/R5Lr6Q0qHI
Dr. John Cush @RheumNow ( View Tweet )
2 years 7 months ago
How early is early in psoriatic arthritis? Is there a window of opportunity for treatment in PsA to ensure optimal outcomes? https://t.co/SHA8Gdm1GD https://t.co/GbFfeB2Euw
Dr. John Cush @RheumNow ( View Tweet )
2 years 7 months ago
Cancer and TNF inhibitors Cancer risk minimisation is a high priority for people with rheumatic diseases, as it is for the general population. Tumor necrosis factor inhibitors (TNFi) have a long history of association with cancer risk discussions https://t.co/MzksmSEUjf https://t.co/dxCIHxL1gc
Dr. John Cush @RheumNow ( View Tweet )
2 years 7 months ago
Watch: SpA Insights: New Therapies https://t.co/01wwJIkmRJ https://t.co/tMJufATzyd
Dr. John Cush @RheumNow ( View Tweet )
2 years 7 months ago
#ACRbest Abstracts – Day 2 Our reporters have been prolific in finding the hot abstracts, those that were most attended or those that are getting the most buzz on social media. Here are RheumNows #ACRbest abstract reports from Monday, 11/13 at #ACR23. https://t.co/yIYYI7IVBD https://t.co/86Nt1mVha8
Dr. John Cush @RheumNow ( View Tweet )
2 years 7 months ago
Monitoring the Effect of Upadacitinib Therapy with a Smart Watch? https://t.co/z6durHZ57R https://t.co/wSJiWNOx9M
Dr. John Cush @RheumNow ( View Tweet )
2 years 7 months ago
Lupus Topic Panel Featuring panelists Dr. Kathryn Dao, Eric Dein and Sheila Reyes, discussing the best and most interesting lupus studies presented at #ACR23. https://t.co/QWR17kOkHD https://t.co/jpaUI2X2Fc
Dr. John Cush @RheumNow ( View Tweet )
2 years 7 months ago
Will CAR T Cells also treat RA? Dr. Jonathan Kay reports on abstract 0424 from #ACR23 https://t.co/xPMmVNZdAC https://t.co/8b3AmjzvML
Dr. John Cush @RheumNow ( View Tweet )
2 years 7 months ago
×